[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Softer Wednesday Afternoon",
    "summary": "Health care stocks were edging lower Wednesday afternoon, with the NYSE Health Care Index and the He",
    "url": "https://finnhub.io/api/news?id=8e826d2ff10d79664071a6d71678cda1e830b4741b9215c43a1dc84b8b8221c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752084087,
      "headline": "Sector Update: Health Care Stocks Softer Wednesday Afternoon",
      "id": 135837174,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Health care stocks were edging lower Wednesday afternoon, with the NYSE Health Care Index and the He",
      "url": "https://finnhub.io/api/news?id=8e826d2ff10d79664071a6d71678cda1e830b4741b9215c43a1dc84b8b8221c9"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why CVS Health (CVS) is a Strong Value Stock",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=d6ed8e63c39ec1b5b41e6a9f0585620b8cd525b3aea70507b5af7a8991fb55bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752068402,
      "headline": "Here's Why CVS Health (CVS) is a Strong Value Stock",
      "id": 135836120,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=d6ed8e63c39ec1b5b41e6a9f0585620b8cd525b3aea70507b5af7a8991fb55bb"
    }
  },
  {
    "ts": null,
    "headline": "How to Find Strong Buy Medical Stocks Using the Zacks Rank",
    "summary": "Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.",
    "url": "https://finnhub.io/api/news?id=46b1b25aebf042ada599bd1dd6f4216e016c53a0de333b418b6b271a55420965",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752068401,
      "headline": "How to Find Strong Buy Medical Stocks Using the Zacks Rank",
      "id": 135836121,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.",
      "url": "https://finnhub.io/api/news?id=46b1b25aebf042ada599bd1dd6f4216e016c53a0de333b418b6b271a55420965"
    }
  },
  {
    "ts": null,
    "headline": "Update: Market Chatter: CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions",
    "summary": "(Updates with the company statement from the third paragraph.) CVS Health's (CVS) Omnicare unit w",
    "url": "https://finnhub.io/api/news?id=37a6639025f070e11017296418468964a241e0c9566bbaf2e1bb9597e13f6f1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752065377,
      "headline": "Update: Market Chatter: CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions",
      "id": 135836122,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "(Updates with the company statement from the third paragraph.) CVS Health's (CVS) Omnicare unit w",
      "url": "https://finnhub.io/api/news?id=37a6639025f070e11017296418468964a241e0c9566bbaf2e1bb9597e13f6f1c"
    }
  },
  {
    "ts": null,
    "headline": "Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?",
    "summary": "CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.",
    "url": "https://finnhub.io/api/news?id=6701d150dc16eeb4baa983f66ae705f761d96aeff7e07079c66ccaab5bafa3fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752063300,
      "headline": "Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?",
      "id": 135835762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.",
      "url": "https://finnhub.io/api/news?id=6701d150dc16eeb4baa983f66ae705f761d96aeff7e07079c66ccaab5bafa3fa"
    }
  },
  {
    "ts": null,
    "headline": "Welsh, Carson, Anderson & Stowe Announces Brian Kane as Senior Advisor",
    "summary": "Welsh, Carson, Anderson & Stowe (\"WCAS\"), a leading private equity firm focused on healthcare and technology, today announced that Brian Kane has become a Senior Advisor to its Healthcare Group.",
    "url": "https://finnhub.io/api/news?id=3c3fa7d276548db522db57fee1f203d86fb5f8b219e5bf9792ece53ed51822c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752059700,
      "headline": "Welsh, Carson, Anderson & Stowe Announces Brian Kane as Senior Advisor",
      "id": 135836124,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Welsh, Carson, Anderson & Stowe (\"WCAS\"), a leading private equity firm focused on healthcare and technology, today announced that Brian Kane has become a Senior Advisor to its Healthcare Group.",
      "url": "https://finnhub.io/api/news?id=3c3fa7d276548db522db57fee1f203d86fb5f8b219e5bf9792ece53ed51822c9"
    }
  },
  {
    "ts": null,
    "headline": "Covered Call Screener Results For July 9th",
    "summary": "Covered calls are a great strategy to add to any portfolio, and can offer enhanced yield from stock holdings, in some case, that can be a significant increase.",
    "url": "https://finnhub.io/api/news?id=b187f922806ca99ccb33416d7a3a8c4c26ada32af0445a0cb0a8b145b4801f6f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752058803,
      "headline": "Covered Call Screener Results For July 9th",
      "id": 135835706,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Covered calls are a great strategy to add to any portfolio, and can offer enhanced yield from stock holdings, in some case, that can be a significant increase.",
      "url": "https://finnhub.io/api/news?id=b187f922806ca99ccb33416d7a3a8c4c26ada32af0445a0cb0a8b145b4801f6f"
    }
  },
  {
    "ts": null,
    "headline": "CVS Omnicare ordered to pay $949 million in government fraud case",
    "summary": "CVS plans to appeal the judgment, which comes after a jury ruled that its long-term care pharmacy benefits manager illegally charged Medicare, Medicaid and Tricare for prescription drugs for almost a decade.",
    "url": "https://finnhub.io/api/news?id=e91adb7a35567cc77cd588cf93bdd3120460975d12202486efb477287eb7fc85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752051902,
      "headline": "CVS Omnicare ordered to pay $949 million in government fraud case",
      "id": 135836126,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS plans to appeal the judgment, which comes after a jury ruled that its long-term care pharmacy benefits manager illegally charged Medicare, Medicaid and Tricare for prescription drugs for almost a decade.",
      "url": "https://finnhub.io/api/news?id=e91adb7a35567cc77cd588cf93bdd3120460975d12202486efb477287eb7fc85"
    }
  },
  {
    "ts": null,
    "headline": "Oakmark U.S. Equity Market Q2 2025 Commentary",
    "summary": "Oakmark U.S. Equity Market Q2 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=25c364aa194e950bfe002ac3bd760d1c6aaf5c35cc17c14193f57b21ac5a5bf2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752033600,
      "headline": "Oakmark U.S. Equity Market Q2 2025 Commentary",
      "id": 135831530,
      "image": "",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=25c364aa194e950bfe002ac3bd760d1c6aaf5c35cc17c14193f57b21ac5a5bf2"
    }
  }
]